Crossmark

Efficacy and Safety of Levosimendan in Severe Cardiac Dysfunction in Children Undergoing Cancer Chemotherapy and Hematopoietic Stem Cell Transplantation

Crossref DOI link: https://doi.org/10.1007/s12288-025-01963-7

Published Online: 2025-01-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mehta, Rachit

Jayakumar, Indira

Manne, Prasad

Uppuluri, Ramya https://orcid.org/0000-0001-5771-8214
Raj, Revathi
License Information

Text and Data Mining valid from 2025-01-17

Version of Record valid from 2025-01-17
More Information

Article History

Received: 29 October 2024

Accepted: 27 December 2024

First Online: 17 January 2025

Declarations

:

: There are no conflicts of interest.

Document is current

Any future updates will be listed below